Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 621)
Posted On: 01/08/2021 6:39:54 PM
Post# of 153992
Posted By: MarcS
Re: calstang #71960
No, they will NOT combine the drug arm of the 394 with the open label arm.
That's not how clinical trials work.
Double blinded clinical trials require all patients in either arm to be double blinded.
You can't add open label to the drug arm of the double blinded portion of the clinical trial.
The drug arm is distinct from the new open label arm.













(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site